Cargando…
Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries
Objectives: This study aims to examine the impact of external price referencing (EPR) on on-patent medicine prices, adjusting for other factors that may affect price levels such as sales volume, exchange rates, gross domestic product (GDP) per capita, total pharmaceutical expenditure (TPE), and size...
Autores principales: | Leopold, Christine, Mantel-Teeuwisse, Aukje Katja, Seyfang, Leonhard, Vogler, Sabine, de Joncheere, Kees, Laing, Richard Ogilvie, Leufkens, Hubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dr. Zaheer-Ud-Din Babar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606937/ https://www.ncbi.nlm.nih.gov/pubmed/23532710 |
Ejemplares similares
-
Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing
por: Vogler, Sabine, et al.
Publicado: (2019) -
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation
por: Vogler, Sabine, et al.
Publicado: (2020) -
Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015) -
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
por: Leopold, Christine, et al.
Publicado: (2014) -
The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)